MT Pharma America's Radicava secures FDA approval to treat ALS

MT Pharma America has secured the US Food and Drug Administration (FDA) approval for Radicava (edaravone) as an intravenous infusion treatment for patients affected with amyotrophic lateral sclerosis (ALS).
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news